Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation in drug development: Recent advances and future challenges
Jian H. Song, Mingzheng Hu, Jun Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115839-115839
Closed Access | Times Cited: 14

Showing 14 citing articles:

PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 10
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access
Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025)
Open Access
Targeted degradation of membrane and extracellular proteins with LYTACs
Yuyang Li, Yang Yang, Renshuai Zhang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 4
Targeting Moonlighting Enzymes in Cancer
Chunxu Lin, Mingyang Yu, Ximei Wu, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1573-1573
Open Access | Times Cited: 2
Development of natural product-based targeted protein degraders as anticancer agents
Cheng Chen, Yanyan Feng, Chen Zhou, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107772-107772
Closed Access | Times Cited: 1
Targeting glucocorticoid receptor signaling pathway for treatment of stress-related brain disorders
Tansu Göver, Michał Ślęzak
Pharmacological Reports (2024)
Open Access | Times Cited: 1
Intracellular Degradation of SARS-CoV-2 N-protein Caused by Modular Nanotransporters Containing Anti-N-protein Monobody and a Sequence that Recruits the Keap1 E3 Ligase
Yuri V. Khramtsov, A. V. Ulasov, T. N. Lupanova, et al.
(2023)
Open Access | Times Cited: 2
Lysosomal Degradation of Extracellular Targets: Innovations and Implications
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 752-754
Open Access
Probing Class I Histone Deacetylases (Hdac) with Proteolysis Targeting Chimera (Protac) for the Development of Highly Potent and Selective Degraders
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders
Hany S. Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107887-107887
Open Access
Modular Assembly of Heterotrifunctional Molecules Enabled by Iodosulfonylation of Allenes and Subsequent Amination
Xiaofeng Lin, Peng Cao, Shijie Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Targeting the ubiquitin proteasome system in cancer stem cells
Hind Atta, Dina H. Kassem, Mohamed M. Kamal, et al.
Trends in Cell Biology (2024)
Closed Access
Research progress in deubiquitinase OTUD3.
Dan Hou, Dan Yu, Guoshuai Yang, et al.
PubMed (2024) Vol. 49, Iss. 8, pp. 1341-1352
Closed Access
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase
Yuri V. Khramtsov, A. V. Ulasov, T. N. Lupanova, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 4-4
Open Access | Times Cited: 1
Page 1

Scroll to top